Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2494587

C[C@@H](N)C(=O)N(C)C.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 17/20 0.39
DPP7 Q9UHL4 14/20 0.39
DPP8 Q6V1X1 10/20 0.37
DPP9 Q86TI2 6/20 0.37
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL186212 1.00 DPP4 (0.39) DPP4DPP7DPP8DPP9KCNH2
Trifluoroacetic Acid SCHEMBL28496842 1.00 DPP4 (0.39) DPP4DPP7DPP8DPP9KCNH2
SCHEMBL634266 0.83
SCHEMBL318931 0.83
SCHEMBL318932 0.83
Bromide SCHEMBL10872395 0.81
Hydrochloric Acid SCHEMBL2384720 0.81
Hydrochloric Acid SCHEMBL1465093 0.81
Hydrochloric Acid SCHEMBL1465090 0.81
Hydrochloric Acid SCHEMBL28931271 0.81 DPP4 (0.36) DPP4DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 DPP4 2704/4885DPP7 3265/4885DPP8 2961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.